Resources

  • Benefit-Risk SIG
  • Biomarkers SIG
  • Board of Directors
  • Bye-Laws
  • Careers and Academic Liaison
  • Committee Operating Guidelines
  • Conference
  • Council of Biopharmaceutical Statistics (CBS)
  • Epidemiology SIG
  • European Links (EFSPI)
  • External Affairs
  • Finance
  • HTA SIG
  • Introduction to Industry
  • Membership
  • Meta-Analysis Expert Group
  • Modelling and Simulation SIG
  • New Starters SIG
  • Publications
  • Regulatory
  • RSS
  • Scientific
  • Statistical Computing Committee
  • Toxicology SIG
  • Training
  • Webinars

Latest News


Show all news

EventsFuture Events


  • Expert Working Group on Confidentiality of Interim Results - Dates: 11 May, 2017

    The PSI/EFSPI expert working group on Confidentiality of Interim Results are planning to meet face to face on 11 May.
  • Estimating Sample Sizes in Clinical Trials - Dates: 28 – 29 Jun, 2017

    The three most important aspects of a clinical trial are: design, design and design. A sample size estimate is just one aspect of a clinical study design. The course describes calculations for sample size estimation in the design of clinical trials. It will be highlighted how the objectives of a clinical trial will impact on sample size calculations. The course is a practical course and all methods will be illustrated with examples and case studies.
Leeds-80x250

Medical Statistician / Senior Medical Statistician

read more...

GSK logo

Director, Statistics

read more...

Astrazeneca

Associate Director, Statistics Team leader - Early Clinical Development

read more...

Astrazeneca

Early Clinical Development – various levels

read more...

LOGO

Biostatistics Head of Department

read more...

Astrazeneca

Principal Statistician – Centralised Statistical Monitoring

read more...

Astrazeneca

Clinical Trial Design Methodology Expert - Statistical Innovation Team

read more...